Keyword: anti-cancer therapeutics


Quantro and Boehringer Ingelheim Hit Milestone in Cancer Treatment Development

05.06.2024 -

Quantro Therapeutics, which focuses on transcription factors targeting cancer treatments, announced that it has reached a key milestone in its joint R&D program with...


Novartis to Acquire Mariana Oncology

03.05.2024 -

Swiss drugmaker Novartis agreed to acquire Mariana Oncology, a US biotechnology company based in Watertown, Massachusetts, that develops novel radioligand therapies (RLTs...


Ono to Acquire Deciphera for $2.4 Billion

02.05.2024 -

Japan’s Ono Pharmaceutical agreed to acquire US cancer-therapy company Deciphera Pharmaceuticals for approximately $2.4 billion. Deciphera focuses on innovative cancer...


Genmab to Acquire ProfoundBio for $1.8 Billion

04.04.2024 -

Danish drugmaker Genmab has agreed to buy privately-owned US biotechnology company ProfoundBio for $1.8 billion. ProfoundBio develops novel ADCs and ADC technologies for...


Lonza, OncoMed to Collaborate on Anti-Cancer Therapeutics

23.10.2012 - Lonza and OncoMed Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced today an agreement for the development and...